We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Pharmacy benefit managers took their turn on the drug pricing hot seat Tuesday as Senators grilled five executives about their role in a system that both parties agree is out of control. Read More
Two drug companies are pushing back against proposed FDA guidance that would require drug sponsors to hold pre-trials to determine whether patients with a nasty form of esophageal swelling could benefit from an alternate therapy. Read More
British regulators will continue to issue EU-required Certificates of Pharmaceutical Product (CPPs) even if there is no formal Brexit agreement, the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) said on Monday. Read More
The House and Senate will each take a hard look at drug prices Tuesday, one in a mark-up that would require drugmakers to make public justifications for price increases or high launch prices, the other in a hearing that will gather executives from some of the nation’s largest pharmacy benefit managers. Read More
Three drugmakers have agreed to pay nearly $123 million to settle separate claims that they defrauded the government through an elaborate kickback scheme involving charitable foundations. Read More